284 related articles for article (PubMed ID: 15113693)
21. pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.
Fasciglione GF; Marini S; D'Alessio S; Politi V; Coletta M
Biophys J; 2000 Oct; 79(4):2138-49. PubMed ID: 11023917
[TBL] [Abstract][Full Text] [Related]
22. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate.
Welch AR; Holman CM; Browner MF; Gehring MR; Kan CC; Van Wart HE
Arch Biochem Biophys; 1995 Dec; 324(1):59-64. PubMed ID: 7503560
[TBL] [Abstract][Full Text] [Related]
23. A caged substrate peptide for matrix metalloproteinases.
Decaneto E; Abbruzzetti S; Heise I; Lubitz W; Viappiani C; Knipp M
Photochem Photobiol Sci; 2015 Feb; 14(2):300-7. PubMed ID: 25418033
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
[TBL] [Abstract][Full Text] [Related]
25. Thioester hydrolysis by matrix metalloproteinases.
Stein RL; Izquierdo-Martin M
Arch Biochem Biophys; 1994 Jan; 308(1):274-7. PubMed ID: 8311464
[TBL] [Abstract][Full Text] [Related]
26. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME
Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369
[TBL] [Abstract][Full Text] [Related]
27. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
28. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
[TBL] [Abstract][Full Text] [Related]
29. Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase.
Ye QZ; Johnson LL; Yu AE; Hupe D
Biochemistry; 1995 Apr; 34(14):4702-8. PubMed ID: 7718575
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
Pennington MW; Thornberry NA
Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
[TBL] [Abstract][Full Text] [Related]
31. Comparison of native matrix metalloproteinases and their recombinant catalytic domains using a novel radiometric assay.
Brownell J; Earley W; Kunec E; Morgan BA; Olyslager B; Wahl RC; Houck DR
Arch Biochem Biophys; 1994 Oct; 314(1):120-5. PubMed ID: 7944383
[TBL] [Abstract][Full Text] [Related]
32. In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors.
Bawadi HA; Antunes TM; Shih F; Losso JN
J Agric Food Chem; 2004 Jul; 52(15):4730-6. PubMed ID: 15264907
[TBL] [Abstract][Full Text] [Related]
33. Influence of oleic acid on the expression, activation and activity of gelatinase A produced by oncogene-transformed human bronchial epithelial cells.
Polette M; Huet E; Birembaut P; Maquart FX; Hornebeck W; Emonard H
Int J Cancer; 1999 Mar; 80(5):751-5. PubMed ID: 10048978
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of fluorogenic trypsin peptide substrates based on resonance energy transfer.
Grahn S; Ullmann D; Jakubke H
Anal Biochem; 1998 Dec; 265(2):225-31. PubMed ID: 9882396
[TBL] [Abstract][Full Text] [Related]
35. The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.
Levin JI; Chen J; Du M; Hogan M; Kincaid S; Nelson FC; Venkatesan AM; Wehr T; Zask A; DiJoseph J; Killar LM; Skala S; Sung A; Sharr M; Roth C; Jin G; Cowling R; Mohler KM; Black RA; March CJ; Skotnicki JS
Bioorg Med Chem Lett; 2001 Aug; 11(16):2189-92. PubMed ID: 11514167
[TBL] [Abstract][Full Text] [Related]
36. Immunopurification and characterization of a collagenase/gelatinase domain issued from basement membrane fibronectin.
Boudjennah L; Dalet-Fumeron V; Ylätupa S; Pagano M
FEBS Lett; 1996 Aug; 391(1-2):52-6. PubMed ID: 8706929
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
Lively TJ; Bosco DB; Khamis ZI; Sang QX
Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
[TBL] [Abstract][Full Text] [Related]
38. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
[TBL] [Abstract][Full Text] [Related]
39. A phosphotyrosine-containing quenched fluorogenic peptide as a novel substrate for protein tyrosine phosphatases.
Nishikata M; Suzuki K; Yoshimura Y; Deyama Y; Matsumoto A
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):385-91. PubMed ID: 10510304
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Minond D; Lauer-Fields JL; Nagase H; Fields GB
Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
